Al Hammadi Holding Co. posted a surge in 9M 2022 net profit after Zakat and tax to SAR 184.2 million, compared to SAR 79.4 million a year earlier.
Item | 9m 2021 | 9m 2022 | Change |
---|---|---|---|
Revenues | 670.10 | 779.75 | 16.4 % |
Gross Income | 255.52 | 288.67 | 13.0 % |
Operating Income | 105.97 | 187.51 | 77.0 % |
Net Income | 79.42 | 184.17 | 131.9 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.50 | 1.15 | 131.9 % |
The profit surge was buoyed by a 16.36% year-on-year (YoY) rise in revenue from the medical services segment at Al Hammadi Nuzha and Suwaidi branches, on increased number of outpatients and inpatients, compared with the same period last year.
The loss from discontinued operations at Al Hammadi Olaya Hospital for the first nine months of 2021 amounted to SAR 8.78 million, as the hospital’s activities were suspended, as part of the company’s plan to replace it with a new hospital.
Al Hammadi also reported a decrease in the provision for credit losses during the current period compared to the 9M 2021 provision, based on the updated data related to the amounts expected to be recovered and used in the model for calculating expected credit losses in accordance with the IFRS 9 requirements.
In Q3 2022, net profit after Zakat and tax skyrocketed to SAR 57.1 million, from SAR 3.58 million, as revenue from the medical services segment at Al Hammadi Nuzha and Suwaidi branches jumped 12.28% YoY. The loss from discontinued operations at Al Hammadi Olaya Hospital reached SAR 36.74 million.
The company’s net profit after Zakat and tax dropped by 12.3% year-on-year from SAR 65.10 million in Q2 2022, hit by a 12.42% drop in revenues of medical services and pharmaceutical products segments at Al Hammadi Nuzha and Suwaidi branches for the current quarter.
Item | Q3 2021 | Q3 2022 | Change |
---|---|---|---|
Revenues | 219.92 | 246.92 | 12.3 % |
Gross Income | 88.16 | 83.50 | (5.3 %) |
Operating Income | 49.65 | 52.33 | 5.4 % |
Net Income | 3.58 | 57.11 | 1494.9 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.02 | 0.36 | 1494.9 % |
Item | Q2 2022 | Q3 2022 | Change |
---|---|---|---|
Revenues | 281.94 | 246.92 | (12.4 %) |
Gross Income | 109.09 | 83.50 | (23.5 %) |
Operating Income | 70.02 | 52.33 | (25.3 %) |
Net Income | 65.10 | 57.11 | (12.3 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.41 | 0.36 | (12.3 %) |
Shareholders’ equity, after minority interest, dropped to SAR 1.698 billion as of Sept. 30, 2022, from SAR 1.720 million a year earlier.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2013 | 104.84 | - | 47.34 | - | 30.09 | - |
Q2 2013 | 108.85 | - | 45.84 | - | 22.74 | - |
Q3 2013 | 96.26 | - | 36.81 | - | 19.02 | - |
Q4 2013 | 124.13 | - | 55.17 | - | 34.34 | - |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 35.96 | 19.5 % |
Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.77 | 57.3 % |
Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 24.77 | 30.3 % |
Q4 2014 | 129.43 | 4.3 % | 55.99 | 1.5 % | 34.52 | 0.5 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 33.35 | (7.3 %) |
Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 37.91 | 6.0 % |
Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 31.92 | 28.8 % |
Q4 2015 | 157.70 | 21.8 % | 68.06 | 21.6 % | 40.39 | 17.0 % |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 143.57 | 9.6 % |
Q1 2016 | 144.16 | 11.3 % | 54.75 | 8.1 % | 26.66 | (20.0 %) |
Q2 2016 | 138.08 | 0.5 % | 57.56 | (9.5 %) | 27.63 | (27.1 %) |
Q3 2016 | 141.35 | 3.3 % | 56.48 | (2.6 %) | 25.97 | (18.6 %) |
Q4 2016 | 182.65 | 15.8 % | 73.35 | 7.8 % | 18.58 | (54.0 %) |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 98.81 | (31.2 %) |
Q1 2017 | 180.23 | 25.0 % | 62.02 | 13.3 % | 33.61 | 26.0 % |
Q2 2017 | 176.71 | 28.0 % | 58.16 | 1.0 % | 32.88 | 19.0 % |
Q3 2017 | 163.01 | 15.3 % | 53.91 | (4.5 %) | 26.46 | 1.9 % |
Q4 2017 | 188.69 | 3.3 % | 65.08 | (11.3 %) | 33.93 | 82.6 % |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 126.88 | 28.4 % |
Q1 2018 | 200.67 | 11.3 % | 66.84 | 7.8 % | 38.29 | 13.9 % |
Q2 2018 | 214.49 | 21.4 % | 53.28 | (8.4 %) | 28.26 | (14.0 %) |
Q3 2018 | 250.40 | 53.6 % | 64.92 | 20.4 % | 31.19 | 17.9 % |
Q4 2018 | 228.04 | 20.9 % | 65.32 | 0.4 % | 29.53 | (13.0 %) |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
Q1 2019 | 229.68 | 14.5 % | 65.60 | (1.9 %) | 27.20 | (29.0 %) |
Q2 2019 | 253.83 | 18.3 % | 71.08 | 33.4 % | 30.95 | 9.5 % |
Q3 2019 | 220.00 | (12.1 %) | 62.22 | (4.2 %) | 31.85 | 2.1 % |
Q4 2019 | 270.55 | 18.6 % | 83.72 | 28.2 % | 39.60 | 34.1 % |
2019 | 974.06 | 9.0 % | 282.62 | 12.9 % | 129.59 | 1.8 % |
Q1 2020 | 206.69 | (10.0 %) | 66.48 | 1.3 % | 33.84 | 24.4 % |
Q2 2020 | 244.30 | (3.8 %) | 90.81 | 27.7 % | 53.15 | 71.8 % |
Q3 2020 | 207.85 | (5.5 %) | 77.59 | 24.7 % | 43.13 | 35.4 % |
Q4 2020 | 230.47 | (14.8 %) | 68.48 | (18.2 %) | 19.33 | (51.2 %) |
2020 | 764.06 | (21.6 %) | 252.83 | (10.5 %) | 103.91 | (19.8 %) |
Q1 2021 | 226.29 | 9.5 % | 87.41 | 31.5 % | 22.69 | (32.9 %) |
Q2 2021 | 223.90 | (8.4 %) | 79.96 | (11.9 %) | 33.63 | (36.7 %) |
Q3 2021 | 219.92 | 5.8 % | 88.16 | 13.6 % | 49.65 | 15.1 % |
Q4 2021 | 281.78 | 22.3 % | 108.53 | 58.5 % | 19.27 | (0.3 %) |
2021 | 951.89 | 24.6 % | 364.05 | 44.0 % | 125.24 | 20.5 % |
Q1 2022 | 250.89 | 10.9 % | 96.08 | 9.9 % | 65.16 | 187.1 % |
Q2 2022 | 281.94 | 25.9 % | 109.09 | 36.4 % | 70.02 | 108.2 % |
Q3 2022 | 246.92 | 12.3 % | 83.50 | (5.3 %) | 52.33 | 5.4 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 143.57 | 9.6 % |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 98.81 | (31.2 %) |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 126.88 | 28.4 % |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
2019 | 974.06 | 9.0 % | 282.62 | 12.9 % | 129.59 | 1.8 % |
2020 | 764.06 | (21.6 %) | 252.83 | (10.5 %) | 103.91 | (19.8 %) |
2021 | 951.89 | 24.6 % | 364.05 | 44.0 % | 125.24 | 20.5 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2013 | 29.83 | - | 0.19 | - | 29.83 | 0.19 |
Q2 2013 | 30.06 | - | 0.19 | - | 24.06 | 0.15 |
Q3 2013 | 18.32 | - | 0.11 | - | 18.32 | 0.11 |
Q4 2013 | 33.29 | - | 0.21 | - | 33.29 | 0.21 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
Q1 2014 | 34.23 | 14.7 % | 0.21 | - | 34.23 | 0.21 |
Q2 2014 | 35.60 | 18.4 % | 0.22 | - | 35.60 | 0.22 |
Q3 2014 | 25.42 | 38.7 % | 0.16 | - | 25.42 | 0.16 |
Q4 2014 | 33.71 | 1.2 % | 0.21 | - | 33.71 | 0.21 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
Q1 2015 | 41.01 | 19.8 % | 0.26 | 9.80 | 31.21 | 0.20 |
Q2 2015 | 36.89 | 3.6 % | 0.23 | - | 36.89 | 0.23 |
Q3 2015 | 27.69 | 8.9 % | 0.17 | - | 27.69 | 0.17 |
Q4 2015 | 35.75 | 6.0 % | 0.22 | - | 35.75 | 0.22 |
2015 | 141.33 | 9.6 % | 0.88 | 9.80 | 131.53 | 0.82 |
Q1 2016 | 21.14 | (48.5 %) | 0.13 | - | 21.14 | 0.13 |
Q2 2016 | 20.63 | (44.1 %) | 0.13 | - | 20.63 | 0.13 |
Q3 2016 | 20.73 | (25.1 %) | 0.13 | - | 20.73 | 0.13 |
Q4 2016 | 10.48 | (70.7 %) | 0.07 | - | 10.48 | 0.07 |
2016 | 72.96 | (48.4 %) | 0.46 | - | 72.96 | 0.46 |
Q1 2017 | 27.97 | 32.3 % | 0.17 | - | 27.97 | 0.17 |
Q2 2017 | 25.66 | 24.4 % | 0.16 | - | 25.66 | 0.16 |
Q3 2017 | 23.59 | 13.8 % | 0.15 | - | 23.59 | 0.15 |
Q4 2017 | 30.76 | 193.4 % | 0.19 | - | 30.76 | 0.19 |
2017 | 107.97 | 48.0 % | 0.67 | - | 107.97 | 0.67 |
Q1 2018 | 30.88 | 10.4 % | 0.19 | - | 30.88 | 0.19 |
Q2 2018 | 19.93 | (22.3 %) | 0.12 | - | 19.93 | 0.12 |
Q3 2018 | 21.31 | (9.7 %) | 0.13 | - | 21.31 | 0.13 |
Q4 2018 | 17.70 | (42.5 %) | 0.11 | - | 17.70 | 0.11 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
Q1 2019 | 24.17 | (21.7 %) | 0.15 | - | 24.17 | 0.15 |
Q2 2019 | 20.01 | 0.4 % | 0.13 | - | 20.01 | 0.13 |
Q3 2019 | 21.17 | (0.6 %) | 0.13 | - | 21.17 | 0.13 |
Q4 2019 | 27.65 | 56.2 % | 0.17 | - | 27.65 | 0.17 |
2019 | 93.00 | 3.5 % | 0.58 | - | 93.00 | 0.58 |
Q1 2020 | 24.94 | 3.2 % | 0.16 | - | 24.94 | 0.16 |
Q2 2020 | 39.10 | 95.4 % | 0.24 | (4.99) | 44.10 | 0.28 |
Q3 2020 | 36.57 | 72.7 % | 0.23 | - | 36.57 | 0.23 |
Q4 2020 | 30.21 | 9.3 % | 0.19 | - | 30.21 | 0.19 |
2020 | 130.83 | 40.7 % | 0.82 | (4.99) | 135.82 | 0.85 |
Q1 2021 | 35.54 | 42.5 % | 0.22 | - | 35.54 | 0.22 |
Q2 2021 | 40.31 | 3.1 % | 0.25 | - | 40.31 | 0.25 |
Q3 2021 | 3.58 | (90.2 %) | 0.02 | (39.18) | 42.76 | 0.27 |
Q4 2021 | 10.67 | (64.7 %) | 0.07 | (9.69) | 20.36 | 0.13 |
2021 | 90.09 | (31.1 %) | 0.56 | (48.87) | 138.96 | 0.87 |
Q1 2022 | 61.96 | 74.4 % | 0.39 | - | 61.96 | 0.39 |
Q2 2022 | 65.10 | 61.5 % | 0.41 | - | 65.10 | 0.41 |
Q3 2022 | 57.11 | 1494.9 % | 0.36 | - | 57.11 | 0.36 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
2015 | 141.33 | 9.6 % | 0.88 | 9.80 | 131.53 | 0.82 |
2016 | 72.96 | (48.4 %) | 0.46 | - | 72.96 | 0.46 |
2017 | 107.97 | 48.0 % | 0.67 | - | 107.97 | 0.67 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
2019 | 93.00 | 3.5 % | 0.58 | - | 93.00 | 0.58 |
2020 | 130.83 | 40.7 % | 0.82 | (4.99) | 135.82 | 0.85 |
2021 | 90.09 | (31.1 %) | 0.56 | (48.87) | 138.96 | 0.87 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | 42.66 % | 27.60 % | 24.31 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
Q4 2015 | 42.80 % | 31.06 % | 23.43 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
Q1 2016 | 42.42 % | 30.79 % | 21.09 % |
Q2 2016 | 41.32 % | 30.64 % | 18.24 % |
Q3 2016 | 40.74 % | 29.96 % | 16.90 % |
Q4 2016 | 39.94 % | 25.11 % | 12.04 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
Q1 2017 | 38.83 % | 24.74 % | 12.43 % |
Q2 2017 | 36.71 % | 24.09 % | 12.46 % |
Q3 2017 | 35.22 % | 23.41 % | 12.48 % |
Q4 2017 | 33.75 % | 25.39 % | 15.24 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
Q1 2018 | 33.46 % | 26.03 % | 15.21 % |
Q2 2018 | 31.18 % | 25.45 % | 13.71 % |
Q3 2018 | 29.28 % | 24.60 % | 12.04 % |
Q4 2018 | 28.02 % | 24.14 % | 10.05 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
Q1 2019 | 27.00 % | 22.96 % | 9.01 % |
Q2 2019 | 27.75 % | 22.56 % | 8.65 % |
Q3 2019 | 28.36 % | 23.59 % | 8.92 % |
Q4 2019 | 29.01 % | 23.82 % | 9.55 % |
2019 | 29.01 % | 23.82 % | 9.55 % |
Q1 2020 | 29.81 % | 25.12 % | 9.86 % |
Q2 2020 | 32.21 % | 27.70 % | 12.52 % |
Q3 2020 | 34.28 % | 29.29 % | 14.34 % |
Q4 2020 | 34.11 % | 28.49 % | 15.27 % |
2020 | 33.09 % | 27.20 % | 17.78 % |
Q1 2021 | 35.68 % | 26.87 % | 16.11 % |
Q2 2021 | 35.28 % | 25.58 % | 16.05 % |
Q3 2021 | 35.98 % | 26.21 % | 16.52 % |
Q4 2021 | 38.24 % | 24.65 % | 14.60 % |
2021 | 38.24 % | 24.65 % | 14.60 % |
Q1 2022 | 38.17 % | 28.20 % | 16.94 % |
Q2 2022 | 38.84 % | 29.87 % | 18.38 % |
Q3 2022 | 37.42 % | 29.18 % | 19.27 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2012 | 43.07 % | 27.97 % | 24.89 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
2019 | 29.01 % | 23.82 % | 9.55 % |
2020 | 33.09 % | 27.20 % | 17.78 % |
2021 | 38.24 % | 24.65 % | 14.60 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | 45.15 % | 31.89 % | 28.45 % |
Q2 2013 | 42.11 % | 24.00 % | 22.10 % |
Q3 2013 | 38.24 % | 23.34 % | 19.03 % |
Q4 2013 | 44.45 % | 30.42 % | 26.82 % |
Q1 2014 | 44.83 % | 32.21 % | 28.04 % |
Q2 2014 | 44.12 % | 32.25 % | 29.26 % |
Q3 2014 | 41.11 % | 26.05 % | 23.36 % |
Q4 2014 | 43.26 % | 29.45 % | 26.04 % |
Q1 2015 | 39.11 % | 28.49 % | 24.10 % |
Q2 2015 | 46.28 % | 30.21 % | 26.86 % |
Q3 2015 | 42.37 % | 30.62 % | 20.24 % |
Q4 2015 | 43.16 % | 34.31 % | 22.67 % |
Q1 2016 | 37.98 % | 27.65 % | 14.66 % |
Q2 2016 | 41.68 % | 29.60 % | 14.94 % |
Q3 2016 | 39.95 % | 27.83 % | 14.67 % |
Q4 2016 | 40.16 % | 17.59 % | 5.74 % |
Q1 2017 | 34.41 % | 25.82 % | 15.52 % |
Q2 2017 | 32.91 % | 26.06 % | 14.52 % |
Q3 2017 | 33.07 % | 24.41 % | 14.47 % |
Q4 2017 | 34.49 % | 25.21 % | 16.30 % |
Q1 2018 | 33.31 % | 28.10 % | 15.39 % |
Q2 2018 | 24.84 % | 23.98 % | 9.29 % |
Q3 2018 | 25.93 % | 21.86 % | 8.51 % |
Q4 2018 | 28.65 % | 23.30 % | 7.76 % |
Q1 2019 | 28.56 % | 22.87 % | 10.52 % |
Q2 2019 | 28.00 % | 22.30 % | 7.88 % |
Q3 2019 | 28.28 % | 26.14 % | 9.62 % |
Q4 2019 | 30.94 % | 24.16 % | 10.22 % |
Q1 2020 | 32.17 % | 28.77 % | 12.07 % |
Q2 2020 | 37.17 % | 32.12 % | 18.05 % |
Q3 2020 | 37.33 % | 33.16 % | 17.59 % |
Q4 2020 | 29.72 % | 20.18 % | 13.11 % |
Q1 2021 | 38.63 % | 22.24 % | 15.70 % |
Q2 2021 | 35.71 % | 27.50 % | 18.00 % |
Q3 2021 | 40.09 % | 35.31 % | 19.45 % |
Q4 2021 | 38.51 % | 16.01 % | 7.22 % |
Q1 2022 | 38.29 % | 36.27 % | 24.70 % |
Q2 2022 | 38.69 % | 33.79 % | 23.09 % |
Q3 2022 | 33.82 % | 31.75 % | 23.13 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2013 | 160.00 | - | - | 3.74 |
Q2 2013 | 160.00 | - | - | 3.67 |
Q3 2013 | 160.00 | - | - | 3.78 |
Q4 2013 | 160.00 | 0.70 | 0.66 | 3.66 |
Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
Q4 2014 | 160.00 | 0.81 | 0.81 | 8.25 |
Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
Q4 2015 | 160.00 | 0.88 | 0.82 | 8.66 |
Q1 2016 | 160.00 | 0.76 | 0.76 | 8.80 |
Q2 2016 | 160.00 | 0.66 | 0.66 | 8.37 |
Q3 2016 | 160.00 | 0.61 | 0.61 | 8.50 |
Q4 2016 | 160.00 | 0.46 | 0.46 | 8.56 |
Q1 2017 | 160.00 | 0.50 | 0.50 | 8.75 |
Q2 2017 | 160.00 | 0.53 | 0.53 | 8.89 |
Q3 2017 | 160.00 | 0.55 | 0.55 | 9.04 |
Q4 2017 | 160.00 | 0.67 | 0.67 | 8.67 |
Q1 2018 | 160.00 | 0.69 | 0.69 | 8.85 |
Q2 2018 | 160.00 | 0.66 | 0.66 | 8.98 |
Q3 2018 | 160.00 | 0.64 | 0.64 | 9.11 |
Q4 2018 | 160.00 | 0.56 | 0.56 | 9.24 |
Q1 2019 | 160.00 | 0.52 | 0.52 | 9.40 |
Q2 2019 | 160.00 | 0.52 | 0.52 | 9.51 |
Q3 2019 | 160.00 | 0.52 | 0.52 | 9.63 |
Q4 2019 | 160.00 | 0.58 | 0.58 | 9.79 |
Q1 2020 | 160.00 | 0.59 | 0.59 | 9.95 |
Q2 2020 | 160.00 | 0.71 | 0.74 | 10.21 |
Q3 2020 | 160.00 | 0.80 | 0.83 | 10.42 |
Q4 2020 | 160.00 | 0.82 | 0.85 | 10.62 |
Q1 2021 | 160.00 | 0.88 | 0.92 | 10.47 |
Q2 2021 | 160.00 | 0.89 | 0.89 | 10.73 |
Q3 2021 | 160.00 | 0.69 | 0.93 | 10.75 |
Q4 2021 | 160.00 | 0.56 | 0.87 | 10.37 |
Q1 2022 | 160.00 | 0.73 | 1.03 | 10.47 |
Q2 2022 | 160.00 | 0.88 | 1.19 | 10.56 |
Q3 2022 | 160.00 | 1.22 | 1.28 | 10.61 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2012 | 160.00 | 0.59 | 0.59 | 3.55 |
2013 | 160.00 | 0.70 | 0.70 | 3.66 |
2014 | 160.00 | 0.81 | 0.81 | 8.25 |
2015 | 160.00 | 0.88 | 0.82 | 8.66 |
2016 | 160.00 | 0.46 | 0.46 | 8.56 |
2017 | 160.00 | 0.67 | 0.67 | 8.67 |
2018 | 160.00 | 0.56 | 0.56 | 9.24 |
2019 | 160.00 | 0.58 | 0.58 | 9.79 |
2020 | 160.00 | 0.82 | 0.85 | 10.62 |
2021 | 160.00 | 0.56 | 0.87 | 10.37 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | 51.42 | 51.42 | 5.14 |
Q4 2014 | 48.92 | 48.92 | 4.78 |
Q1 2015 | 51.53 | 55.54 | 5.14 |
Q2 2015 | 54.13 | 58.30 | 5.61 |
Q3 2015 | 44.33 | 47.69 | 4.57 |
Q4 2015 | 41.63 | 44.73 | 4.24 |
Q1 2016 | 36.41 | 36.41 | 3.14 |
Q2 2016 | 45.86 | 45.86 | 3.60 |
Q3 2016 | 36.32 | 36.32 | 2.62 |
Q4 2016 | 68.31 | 68.31 | 3.64 |
Q1 2017 | 61.37 | 61.37 | 3.50 |
Q2 2017 | 58.51 | 58.51 | 3.49 |
Q3 2017 | 47.94 | 47.94 | 2.91 |
Q4 2017 | 41.25 | 41.25 | 3.21 |
Q1 2018 | 39.28 | 39.28 | 3.07 |
Q2 2018 | 37.68 | 37.68 | 2.76 |
Q3 2018 | 32.21 | 32.21 | 2.27 |
Q4 2018 | 33.55 | 33.55 | 2.04 |
Q1 2019 | 35.91 | 35.91 | 1.98 |
Q2 2019 | 30.97 | 30.97 | 1.69 |
Q3 2019 | 32.09 | 32.09 | 1.73 |
Q4 2019 | 27.16 | 27.16 | 1.61 |
Q1 2020 | 24.17 | 24.17 | 1.42 |
Q2 2020 | 23.40 | 22.41 | 1.62 |
Q3 2020 | 27.10 | 26.08 | 2.08 |
Q4 2020 | 26.52 | 25.54 | 2.04 |
Q1 2021 | 24.66 | 23.82 | 2.08 |
Q2 2021 | 33.33 | 33.33 | 2.77 |
Q3 2021 | 42.10 | 31.02 | 2.68 |
Q4 2021 | 53.70 | 34.82 | 2.92 |
Q1 2022 | 46.73 | 32.92 | 3.25 |
Q2 2022 | 41.33 | 30.71 | 3.46 |
Q3 2022 | 36.83 | 35.09 | 4.23 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2012 | - | - | - |
2013 | - | - | - |
2014 | 48.92 | 48.92 | 4.78 |
2015 | 41.63 | 44.73 | 4.24 |
2016 | 68.34 | 68.34 | 3.64 |
2017 | 41.25 | 41.25 | 3.21 |
2018 | 33.55 | 33.55 | 2.04 |
2019 | 27.16 | 27.16 | 1.61 |
2020 | 26.52 | 25.54 | 2.04 |
2021 | 53.70 | 34.82 | 2.92 |
Q3 2022
2022
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
Q1 2017 | 150.74 | 29.49 |
Q2 2017 | 147.45 | 29.26 |
Q3 2017 | 136.70 | 26.31 |
Q4 2017 | 155.95 | 32.73 |
Q1 2018 | 140.85 | 59.82 |
Q2 2018 | 143.64 | 71.39 |
Q3 2018 | 140.83 | 109.03 |
Q4 2018 | 154.81 | 73.23 |
Q1 2019 | 146.91 | 82.77 |
Q2 2019 | 151.05 | 102.78 |
Q3 2019 | 149.00 | 71.00 |
Q4 2019 | 177.92 | 92.62 |
Q1 2020 | 152.48 | 54.21 |
Q2 2020 | 192.83 | 51.46 |
Q3 2020 | 47.34 | 35.26 |
Q4 2020 | 185.43 | 45.04 |
Q1 2021 | 168.82 | 57.47 |
Q2 2021 | 163.87 | 60.02 |
Q3 2021 | 180.27 | 39.64 |
Q4 2021 | 224.93 | 56.85 |
Q1 2022 | 195.39 | 55.50 |
Q2 2022 | 232.25 | 49.69 |
Q3 2022 | 201.88 | 45.04 |
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
2012 | 274.90 | 103.78 |
2013 | 317.00 | 117.11 |
2014 | 360.30 | 121.61 |
2015 | 451.60 | 109.71 |
2016 | 552.40 | 89.11 |
2017 | 590.84 | 117.78 |
2018 | 580.13 | 313.47 |
2019 | 624.88 | 349.18 |
2020 | 578.09 | 185.97 |
2021 | 737.90 | 213.99 |
Item | Q3 2022 (e) | Q3 2022 (a) | Change |
---|---|---|---|
Average | 48.58 | 57.11 | 17.57 % |
Item | Q3 2022 (e) | Q3 2022 (a) | Change |
---|---|---|---|
Al Rajhi Capital | 55.00 | 57.11 | 3.8 % |
AlJazira Capital | 54.40 | 57.11 | 5.0 % |
SNB Capital | 42.50 | 57.11 | 34.4 % |
OSOOL AND BAKHEET | 42.41 | 57.11 | 34.7 % |
Current | |
Market Cap (M Riyal) | 6,144.00 |
Enterprise Value (EV) (M) | 5,905.92 |
Shares Outstanding ((M)) | 160.00 |
EPS ( Riyal) (TTM) | 2.04 |
Book Value (BV) ( Riyal) | 12.11 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 23.23 |
P/E (TTM) | 18.83 |
Price/book | 3.17 |
Return on Average Assets (%) (TTM) | 12.5 |
Return on Average Equity (%) (TTM) | 17.3 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}